Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial ☆-Reference-Cited by-同舟云学术

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial ☆

Published:2008-06 Issue:3 Volume:136 Page:432-444
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:

Author:

Russell Jon I.,Mease Philip J.,Smith Timothy R.,Kajdasz Daniel K.,Wohlreich Madelaine M.,Detke Michael J.,Walker Daniel J.,Chappell Amy S.,Arnold Lesley M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Neurology (clinical),Neurology

Reference39 articles.

1. , for the Duloxetine Fibromyalgia Trial Group. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.;Arnold;Arthritis Rheum,2004

2. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder.;Arnold;Pain,2005

3. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry.;Basbaum;Annu Rev Neurosci,1984

4. Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder.;Bech;Psychopharmacology,2006

5. The fibromyalgia impact questionnaire: development and validation.;Burckhardt;J Rheumatol,1991

Cited by 297 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prazosin as an Adjuvant to Increase Effectiveness of Duloxetine in a Rat Model of Oxaliplatin-Induced Peripheral Neuropathy;Seminars in Oncology Nursing;2024-10

2. Study protocol for the Treating Opioid Patients' Pain and Sadness (TOPPS) study — A randomized control trial to lower depression and chronic pain interference, and increase care retention among persons receiving buprenorphine;Contemporary Clinical Trials;2024-08

3. The association of T102C (rs6313) polymorphism in the 5-HT2A receptor gene with temporomandibular disorders and anxiety in a group of Turkish population;CRANIO®;2024-06-20

4. Pain makes me anxious, and anxiety gives me pain;Case Studies: Stahl's Essential Psychopharmacology;2024-04-30

5. Pharmacotherapy and Medical Management for Neuroma and Neuropathic Pain;Contemporary Neuroma Management;2024